Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-014687
Filing Date
2023-04-28
Accepted
2023-04-28 16:05:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 14132
2 proxy_001.jpg GRAPHIC 283369
3 proxy_002.jpg GRAPHIC 258001
  Complete submission text file 0001493152-23-014687.txt   760851
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-15911 | Film No.: 23865873
SIC: 2834 Pharmaceutical Preparations